Share:
Combined Company to Trade on NASDAQ Post-closing under Tickers: RVPH and RVPHW
NEW YORK and CUPERTINO, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) Reviva Pharmaceuticals Holdings, Inc., a Delaware corporation (
Reviva Holdings ), as the successor to Tenzing Acquisition Corp., a special purpose acquisition company incorporated in the British Virgin Islands (
Tenzing ) (NASDAQ:TZAC), and Reviva Pharmaceuticals, Inc., a Delaware corporation (
Reviva ), a California-based clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced the completion of their previously announced business combination of the two companies (the